{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:45:11Z","timestamp":1777729511451,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jvir.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:36:34Z","timestamp":1723502194000},"page":"1616-1625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for Patients with Unresectable Intrahepatic Cholangiocarcinoma"],"prefix":"10.1016","volume":"35","author":[{"given":"Shuyang","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanwang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huzheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2024.08.006_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.jvir.2024.08.006_bib2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","article-title":"Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival","volume":"43","author":"Wu","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.jvir.2024.08.006_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2024.08.006_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2024.08.006_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2024.08.006_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.RVI.0000143768.60751.78","article-title":"Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution","volume":"16","author":"Burger","year":"2005","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.08.006_bib8","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cncr.23787","article-title":"Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes","volume":"113","author":"Kim","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2024.08.006_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00270-008-9336-2","article-title":"Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results","volume":"31","author":"Aliberti","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.08.006_bib10","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.21873\/anticanres.11522","article-title":"Chemoembolization with drug-eluting microspheres loaded with doxorubicin for the treatment of cholangiocarcinoma","volume":"37","author":"Aliberti","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jvir.2024.08.006_bib11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jvir.2013.03.019","article-title":"Meta-analysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma","volume":"24","author":"Ray","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.08.006_bib12","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1245\/s10434-013-3127-y","article-title":"Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis","volume":"20","author":"Hyder","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2024.08.006_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00432-022-04485-1","article-title":"Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis","volume":"149","author":"He","year":"2023","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jvir.2024.08.006_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1245\/s10434-010-1333-4","article-title":"Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival","volume":"18","author":"Schiffman","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2024.08.006_bib15","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1245\/s10434-022-11932-3","article-title":"Drug-eluting bead, irinotecan therapy of unresectable intrahepatic cholangiocarcinoma (DELTIC) with concomitant systemic gemcitabine and cisplatin","volume":"29","author":"Martin","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2024.08.006_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11547-024-01781-3","article-title":"Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study","volume":"129","author":"Jiang","year":"2024","journal-title":"Radiol Med (Torino)"},{"key":"10.1016\/j.jvir.2024.08.006_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2024.08.006_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2024.08.006_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","article-title":"mRECIST for HCC: Performance and novel refinements","volume":"72","author":"Llovet","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2024.08.006_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jvir.2023.11.015","article-title":"Systemic chemotherapy with or without hepatic arterial infusion chemotherapy for intrahepatic cholangiocarcinoma with extrahepatic oligometastasis: a propensity score-matched analysis","volume":"35","author":"Li","year":"2024","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.08.006_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","article-title":"Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Cercek","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jvir.2024.08.006_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/RLU.0000000000000904","article-title":"Glass microspheres 90Y selective internal radiation therapy and chemotherapy as first-line treatment of intrahepatic cholangiocarcinoma","volume":"40","author":"Edeline","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jvir.2024.08.006_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000525489","article-title":"Selective internal radiation therapy with yttrium-90 resin microspheres followed by gemcitabine plus\u00a0cisplatin for unresectable intrahepatic cholangiocarcinoma: a phase\u00a02 single-arm multicenter clinical trial","volume":"11","author":"Chan","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jvir.2024.08.006_bib25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10637-022-01257-z","article-title":"Combination of TACE and lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma","volume":"40","author":"Yuan","year":"2022","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jvir.2024.08.006_bib26","article-title":"Efficacy and safety of drug-eluting beads transarterial chemoembolization combining immune checkpoint inhibitors in unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvir.2024.08.006_bib27","first-page":"2732","article-title":"The addition of transarterial chemoembolization to palliative chemotherapy extends survival in intrahepatic cholangiocarcinoma","volume":"10","author":"Gairing","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jvir.2024.08.006_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00270-022-03108-z","article-title":"Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety","volume":"45","author":"Liu","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.08.006_bib29","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160247","article-title":"Chemoembolization with drug\u00a0eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study","volume":"89","author":"Venturini","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jvir.2024.08.006_bib30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study","volume":"15","author":"Andr\u00e9","year":"2004","journal-title":"Ann Oncol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324005086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324005086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T08:47:13Z","timestamp":1729673233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324005086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1051044324005086"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2024.08.006","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for Patients with Unresectable Intrahepatic Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2024","name":"copyright","label":"Copyright"}]}}